Work that once took years now takes just a few minutes thanks to this year’s chemistry laureates.
2024 #NobelPrize laureates Demis Hassabis and John Jumper have used their AI model AlphaFold2 to calculate the structure of all human proteins. They also predicted the structure of virtually all the 200 million proteins that researchers have so far discovered when mapping Earth’s organisms.
Google DeepMind has also made the code for AlphaFold2 publicly available, and anyone can access it. The AI model has become a gold mine for researchers. By October 2024, AlphaFold2 had been used by more than two million people from 190 countries.
The picture shows a few of the many examples of how AlphaFold2 helps researchers.
BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2024 #NobelPrize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.”
"Medicinal Chemistry In The Age Of Artificial Intelligence"
Reflections on bold technology claims and drug discovery realism - from @NimbusTx CSO Peter Tummino.
https://t.co/QokPxhKrP6
We're pleased to announce the companies selected to pitch at our upcoming Invest in BC conference presented by @LumiraVentures!
Secure your spot now to take advantage of early bird pricing!
Find the list of presenting companies here: https://t.co/yzOynr7v0F
#LSBCinvest
Are you curious why BC over-indexes in Canadian life sciences, and why we have held the title for fastest-growing life sciences sector in Canada for several years?
Read more about the innovative BC companies at BIO, including key contact information here: https://t.co/eEz6G3sRBf
@HTuOBiosciences is using physics-based approaches to optimize drug discovery. HTuO will attend BIO as part of the BC Delegation.
Join our webinar on May 23 for an overview of the company's latest innovations ahead of the convention.
Register now: https://t.co/D2rgFyfmM0
The landscape of small-molecule prodrugs https://t.co/q8qsxZesPH
This new review analyses approved prodrugs to reveal trends in their development, highlighting design rationales, indications, mechanisms of API release, chemistry of promoieties and the market impact of prodrugs
Welcome to new BIOTECanada member @HTuOBiosciences as they bring their unique expertise into a vibrant ecosystem of biotech leaders.
Read more about HTuO Biosciences here: https://t.co/goAUiKWlyl
We’re excited to announce that HTuO Biosciences has joined Johnson & Johnson Innovation - @JLABS a premier life science incubator program.
Read more: https://t.co/72QnvQlNgl
#startup#drugdiscovery#drugdevelopment
🔟days to go until the 2024 #OBIO Investment Summit kick off! 🚀We are very excited to showcase remarkable innovations, engage with ecosystem partners and connect global investors with growing companies!
#OBIOInvestmentSummit#OIS2024#OBIOInvestmentSummit2024
This aft Invest in BC presented by Lumira Ventures event, featured the final ten #MedTech and #Biotech companies presenting to a diverse group of intl investors. Thx to Oyen Wiggs and Genome BC, our generous session sponsors. #LSBCinvest https://t.co/V2gANhM5XN
We are excited for the medical devices session at Invest in BC, presented by Lumira Ventures, scheduled for November 2. Christina Kwok from Oyen Wiggs, our generous session sponsor, presents this session. #LSBCinvest
Learn more and register here: https://t.co/miegjMdBiF
We are delighted to announce some of the presenting companies for our upcoming 8th annual Invest in BC event presented by Lumira Ventures on November 2nd! #LSBCInvest
Click here for a list of presenting companies and purchase your tickets for the event:
https://t.co/E8TQT4jF3p
We can't wait for Invest in BC presented by @LumiraVentures! This gathering for healthcare innovators connects you with over 20 investors. #LSBCinvest
Some of the investors:
@CQDM_Canada, CTI Life Sciences , @jpmorgan , and @RisingTideOrg
Learn more:
https://t.co/fZsJFNcJ3k